knowledge -WSS

knowledge

author：explore 2025-10-01 17:35:15 - browse：2

ADAM FEUERSTEIN/STAT

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up here.

CHICAGO — It’s only Day 2, but the ASCO meeting is already in full force. That means hordes of oncologists filling the halls, reams of data streaming through the meeting, and incredibly long lines for even the worst food. And STAT reporters Angus Chen, Adam Feuerstein, and Matthew Herper are in the thick of it – on the heels of STAT’s own in-person event here, which was standing room only and came with its own share of thrills, chills, and not a little bit of audience laughter. More on that in a bit.

Here’s a rundown of some of the big news from the first 24 hours of the meeting which, due to some weird kind of relativistic time dilation, represents about a week for our intrepid reporters.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Biden's 'march

focus

WSS

Microsoft's Peter Lee: Generative AI could help doctors be more human

Florida health officials providing scant details on measles cases

Lack of health data on LGBTQ+ people has serious consequences

Longer MASH drug regimen improved liver, Akero study finds

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

$1 billion proposal to grow Boston, Massachusetts biotech

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Stroke deaths set to near 10 million globally by 2050

Peter Hotez and the public health issue of online harassment

Florida health officials providing scant details on measles cases

The high cost of giving birth even with insurance

A Q&A with the global head of Boehringer Ingelheim's innovation unit

State Dept. review finds Biden bears some blame for Afghanistan failures

3 questions for the future of Biden's cancer moonshot

ChatGPT in medicine: STAT answers readers' burning questions

For AI in health care standards, federal regulators join with industry group

focus

Readout Newsletter: BridgeBio, Akero, and human embryo models

State of the Union pitch: Bigger Medicare drug price negotiations

Streamlined flu vaccines recommended by FDA advisory panel

A new approach to psychiatric drug development

Readout Newsletter: BridgeBio, Akero, and human embryo models

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

focus

focus

focus

Wikipedia